Added to YB: 2024-10-28
Pitch date: 2024-10-25
BEAT [bullish]
HeartBeam, Inc.
-7.26%
current return
Author Info
Triple S is a professional special situations investor who shares ideas in their newsletter. Sign up for the newsletter.
Company Info
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.
Market Cap
$66.8M
Pitch Price
$2.48
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.24
P/E
-2.71
EV/Sales
N/A
Sector
Health Care Equipment and Supplies
Category
growth
A home heart attack monitor (Beat), updates, and other interesting special situations
BEAT: AIMIGo device awaiting FDA clearance (expected 2024), offers portable 12-lead ECG for at-home heart attack detection. AI-enhanced vector tech targets $12B ischemia, $6.6B arrhythmia markets. Potential multi-bagger at <$75M market cap. Risks: regulatory approval, funding, adoption.
Read full article (3 min)